OxSight Onyx Smart Glasses

OxSight Onyx Smart Glasses glasses for the visually impaired. Transform how you live instantly. OXSIGHT Onyx smart glasses are an FDA Class-1 medical device for those with central vision loss associated with such eye conditions as age-related macular degeneration, Stargardt disease, diabetic retinopathy, Leber hereditary optic neuropathy (LHON), retinitis pigmentosa, stroke, and more.

Lighter and more affordable than any comparable device available today, OxSight Onyx Smart Glasses is set to revolutionize the market for wearable low-vision technology. Worn like regular glasses, Onyx features a camera system that projects a magnified live video stream on two OLED display screens in front of the eyes.

Onyx lets users engage their remaining peripheral vision to maintain their balance and be spatially aware of their environment. Onyx's functionality based on artificial intelligence and autofocusing lenses detects text, faces, and objects, adjusting to ambient light conditions. Users can freeze and enlarge images. It provides an automatic ultralow light mode and a TV mode for better vision in those situations.

The rechargeable device weighs 7.4 ounces (210 grams) and is ergonomically designed to sit comfortably on the nose ridge. ONYX starts ups in seconds using intelligent ultrafast boot technology, runs an average of 100 minutes on battery per charge, and comes with a USB charger for continuous operation. A lanyard is included so Onyx can be used as digital binoculars.

Oxsight Onyx Smart Glasses could potentially assist those with the following conditions:

• Inverted Retinitis Pigmentosa
• Myopic Macular (MM)
• Diabetic Macular Oedema Age-Related
• Age-Related Macular Degeneration (AMD)
• Corneal Opacity
• Central Serous Retinopathy (CSR)
• Macular Hole (MH)
• Lebers Hereditary Optic Neuropathy 
• Retinal Vein Occlusion (RVO)
• Punctate Inner Choroidopathy (PIC)
• Diabetic Retinopathy (DR)
• Stroke Related Sight Loss
• Stargardt's Disease
• Macular Dystrophy